NT5E and lung adenocarcinoma: To evaluate the in vivo antitumor activity of the anti-CD73 engineered NK cells, we established a subcutaneous xenograft model using lung adenocarcinoma CD73+ A549 cells engrafted into NRG mice (Figure 5A).